Showing results (111-120 of 401) with videos related to
Sort By:
Pageof 41
European Journal of Haematology|June 9, 2004
WT1 gene expression: useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia?Peter Bader, Charlotte Niemeyer, Gerrit Weber, et al.International Journal of Molecular Sciences|February 15, 2022
A New Perspective for Bone Tissue Engineering: Human Mesenchymal Stromal Cells Well-Survive Cryopreservation on β-TCP Scaffold and Show Increased Ability for Osteogenic DifferentiationLiudmila Leppik, Anna Gempp, Zyrafete Kuçi, et al.Journal of Clinical Apheresis|August 5, 2020
Unstimulated apheresis for chimeric antigen receptor manufacturing in pediatric/adolescent acute lymphoblastic leukemia patientsAndrea Jarisch, Eva Rettinger, Jan Sörensen, et al.Water Research|April 9, 2013
Substance flow analysis as a tool for mitigating the impact of pharmaceuticals on the aquatic systemNathalie Chèvre, Sylvain Coutu, Jonas Margot, et al.Blood|September 14, 2018
Murine pre-B-cell ALL induces T-cell dysfunction not fully reversed by introduction of a chimeric antigen receptorHaiying Qin, Kazusa Ishii, Sang Nguyen, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2017
Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma KinaseAlec J Walker, Robbie G Majzner, Ling Zhang, et al.Journal of Clinical Immunology|March 14, 2026
Syndromic Inborn Errors of Immunity in TREC-Newborn Screening: 5-year Experience from the German Screening ProgramLea Graafen, Carsten Speckmann, Shahrzad Bakhtiar, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 8, 2011
Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomasKristin Baird, Terry J Fry, Seth M Steinberg, et al.Haematologica|August 11, 2022
Potent preclinical activity of FLT3-directed chimeric antigen receptor T-cell immunotherapy against FLT3- mutant acute myeloid leukemia and KMT2A-rearranged acute lymphoblastic leukemiaLisa M Niswander, Zachary T Graff, Christopher D Chien, et al.Journal for Immunotherapy of Cancer|September 17, 2021
Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct designHaiying Qin, Lila Yang, John A Chukinas, et al.Pageof 41